Niche EHR startups like Orchid are joining major companies in developing AI scribe technology to assist with clinical note-taking, particularly in mental health. Orchid’s AI can learn from clinicians’ input, draft clinical notes, summarize medical histories, suggest billing codes, and provide after-visit summaries. Psychiatrist David Halpern has experienced time savings using Orchid, allowing him to see more patients and improve access to mental healthcare.
Orchid’s CEO, Joe Pomianowski, created the platform to reduce clinicians’ administrative burdens, enabling them to focus more on patient care. Orchid automates note-writing by recording sessions, dictating notes, or following existing templates, making it easier for clinicians to accept insurance. The company, backed by investors like Y Combinator, aims to reduce the healthcare system’s $1 trillion administrative burden.
Halpern envisions a future where technology seamlessly integrates into patient care, relieving clinicians of administrative tasks. Orchid plans to add e-prescribing in 2025 and continue supporting clinicians’ needs as they expand. With thousands of users already benefiting from Orchid’s EHR system, the focus remains on improving healthcare outcomes and reducing administrative burdens in the industry.
Source
Photo credit www.hcinnovationgroup.com